Coming months critical for Mirena Pseudotumor Plaintiffs
Coming months critical for Mirena Pseudotumor Plaintiffs
Introduction
Mirena lawsuits' MDL 2767 linked to intracranial hypertension also called pseudotumor cerebri were centralized in April 2017 before Judge Paul A. Engelmayer in the U.S. District Court for the Southern District of New York. This MDL is moving forward speedily. With the first phase of discovery initiated, depositions are taking place proving to be a critical time for the plaintiffs. The defendant, Bayer, continues to maintain that its Mirena is a safe and effective method of birth control. The Daubert Hearings are scheduled to begin early 2018.
Comments
Latest News
Pesticide Shield Bill Faces Long Odds in Missouri Senate
Categories: General
Legislation aimed at making it harder to sue pesticide manufacturers over cancer claims is facing a critical deadline, with an unusual coalition of opponents striving to stall its progress.
…Philips Sues CPAP Cleaner SoClean to Share Settlement Costs
Categories: Settlements
Philips has filed a lawsuit against SoClean, a company that manufactures ozone-based cleaning systems…
NJ Pharma Settles: Cash, Narcan for Delaware
Categories: Settlements
Amneal Pharmaceuticals, a New Jersey-based drug manufacturer, has reached a settlement agreement with Delaware and other states over its involvement in the…